99 related articles for article (PubMed ID: 19420973)
1. Single tissue samples from head and neck squamous cell carcinomas are representative regarding the entire tumor's chemosensitivity to cisplatin and docetaxel.
Wichmann G; Horn IS; Boehm A; Mozet C; Tschop K; Dollner R; Dietz A
Onkologie; 2009 May; 32(5):264-72. PubMed ID: 19420973
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse.
Horn IS; Wichmann G; Mozet C; Dietz A; Dollner R; Tschöp K; Boehm A
Cancer Chemother Pharmacol; 2010 May; 65(6):1153-63. PubMed ID: 19771432
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of lapatinib and cisplatin on colony formation of head and neck squamous cell carcinoma.
Schrader C; Boehm A; Reiche A; Dietz A; Mozet C; Wichmann G
Anticancer Res; 2012 Aug; 32(8):3191-9. PubMed ID: 22843892
[TBL] [Abstract][Full Text] [Related]
4. Stimulation by Monocyte Chemoattractant Protein-1 Modulates the Ex-vivo Colony Formation by Head and Neck Squamous Cell Carcinoma Cells.
Wichmann G; Körner C; Boehm A; Mozet C; Dietz A
Anticancer Res; 2015 Jul; 35(7):3917-24. PubMed ID: 26124338
[TBL] [Abstract][Full Text] [Related]
5. The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma.
Dollner R; Granzow C; Helmke BM; Ruess A; Schad A; Dietz A
Anticancer Res; 2004; 24(1):325-31. PubMed ID: 15015616
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog targeting by cyclopamine suppresses head and neck squamous cell carcinoma and enhances chemotherapeutic effects.
Mozet C; Stoehr M; Dimitrova K; Dietz A; Wichmann G
Anticancer Res; 2013 Jun; 33(6):2415-24. PubMed ID: 23749890
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations.
Dollner R; Granzow C; Neudert M; Dietz A
Anticancer Res; 2006; 26(2B):1651-5. PubMed ID: 16619587
[TBL] [Abstract][Full Text] [Related]
8. Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.
Lee KC; Lee SH; Lee Y; Park SH; Park J; Cho EK; Shin DB; Lee JH; Kim DY; Kim ST
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):187-91. PubMed ID: 17996392
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.
Nozawa H; Tadakuma T; Ono T; Sato M; Hiroi S; Masumoto K; Sato Y
Cancer Sci; 2006 Oct; 97(10):1115-24. PubMed ID: 16984384
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
Tsao AS; Garden AS; Kies MS; Morrison W; Feng L; Lee JJ; Khuri F; Zinner R; Myers J; Papadimitrakopoulou V; Lewin J; Clayman GL; Ang KK; Glisson BS
J Clin Oncol; 2006 Sep; 24(25):4163-9. PubMed ID: 16943532
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
[TBL] [Abstract][Full Text] [Related]
13. Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neck.
Haddad R; Tishler R; Wirth L; Norris CM; Goguen L; Sullivan C; O'Donnell L; Li Y; Posner M
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):678-81. PubMed ID: 16785415
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel in the management of patients with head and neck squamous cell carcinoma.
Bernier J; Vrieling C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
Stoehr M; Mozet C; Boehm A; Aigner A; Dietz A; Wichmann G
Cancer Chemother Pharmacol; 2014 Apr; 73(4):827-37. PubMed ID: 24562588
[TBL] [Abstract][Full Text] [Related]
16. Does dexamethasone inhibit the antineoplastic effect of cisplatin and docetaxel in head and neck cancer cells?
Wagenblast J; Arnoldner C; Gstöttner W; Bisdas S; Mörtel S; May A; Hambek M
Anticancer Res; 2010 Jan; 30(1):123-7. PubMed ID: 20150626
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
18. Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways.
Liebig H; Günther G; Kolb M; Mozet C; Boehm A; Dietz A; Wichmann G
Cancer Chemother Pharmacol; 2017 Feb; 79(2):411-420. PubMed ID: 28110457
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant docetaxel and cisplatin chemotherapy followed by local irradiation is highly active on locoregionally advanced squamous cell carcinoma of the head and neck.
Shin HJ; Chung JS; Choi YJ; Lee BJ; Wang SG; Kim DW; Cho GJ
J Laryngol Otol; 2008 Jul; 122(7):722-7. PubMed ID: 17925058
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
Specenier PM; Van Den Brande J; Schrijvers D; Huizing MT; Altintas S; Dyck J; Van Den Weyngaert D; Van Laer C; Vermorken JB
Anticancer Res; 2009 Dec; 29(12):5137-42. PubMed ID: 20044628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]